Gene regulation in animal miRNA biogenesis

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Bartel D. microRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281–297 (2004).
  Medline CASGoogle Scholar
• 2. Gong H, Vu GP, Bai Y et al. A Salmonella small non-coding RNA facilitates bacterial invasion and intracellular replication by modulating the expression of virulence factors. PLOS Pathog. 7(9), e1002120(2011).
  Medline CASGoogle Scholar
• 3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5), 843–854 (1993).
  Medline CASGoogle Scholar
• 4. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75(5), 855–862 (1993).
  Medline CASGoogle Scholar
• 5. Waddington CH. The epigenotype. 1942. Int. J. Epidemiol. 41(1), 10–13 (2012).
  Medline CASGoogle Scholar
• 6. Bird A. Perceptions of epigenetics. Nature 447(7143), 396–398 (2007).
  Medline CASGoogle Scholar
• 7. Xu Z, Sandler DP, Taylor JA. Blood DNA methylation and breast cancer: a prospective case–cohort analysis in the Sister Study. J. Natl Cancer Inst. 112(1), 87–94 (2020).
  MedlineGoogle Scholar
• 8. Martins de Carvalho L, Chen WY, Lasek AW. Epigenetic mechanisms underlying stress-induced depression. Int. Rev. Neurobiol. 156, 87–126 (2021).
  MedlineGoogle Scholar
• 9. Kogo R, Shimamura T, Mimori K et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71(20), 6320–6326 (2011).
  Medline CASGoogle Scholar
• 10. Chen R, Gan Q, Zhao S et al. DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2. BMC Cancer 22(1), 488 (2022).
  MedlineGoogle Scholar
• 11. Tammen SA, Friso S, Choi S-W. Epigenetics: the link between nature and nurture. Mol. Aspects Med. 34(4), 753–764 (2013).
  Medline CASGoogle Scholar
• 12. Boccaletto P, Machnicka MA, Purta E et al. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 46(D1), D303–D307 (2018).
  Medline CASGoogle Scholar
• 13. Jia G, Fu Y, Zhao X et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7(12), 885–887 (2011).
  Medline CASGoogle Scholar
• 14. Willyard C. A new twist on epigenetics. Nature 542(7642), 406–408 (2017).
  Medline CASGoogle Scholar
• 15. Frye M, Jaffrey SR, Pan T, Rechavi G, Suzuki T. RNA modifications: what have we learned and where are we headed? Nat. Rev. Genet. 17(6), 365–372 (2016).
  Medline CASGoogle Scholar
• 16. Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 47(D1), D155–D162 (2019).
  Medline CASGoogle Scholar
• 17. Ozsolak F, Poling LL, Wang Z et al. Chromatin structure analyses identify miRNA promoters. Genes Dev. 22(22), 3172–3183 (2008).
  Medline CASGoogle Scholar
• 18. Monteys AM, Spengler RM, Wan J et al. Structure and activity of putative intronic miRNA promoters. RNA 16(3), 495–505 (2010).
  MedlineGoogle Scholar
• 19. Dhir A, Dhir S, Proudfoot NJ, Jopling CL. Microprocessor mediates transcriptional termination of long noncoding RNA transcripts hosting microRNAs. Nat. Struct. Mol. Biol. 22(4), 319–327 (2015).
  Medline CASGoogle Scholar
• 20. Altuvia Y, Landgraf P, Lithwick G et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33(8), 2697–2706 (2005).
  Medline CASGoogle Scholar
• 21. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10(12), 1957–1966 (2004).
  Medline CASGoogle Scholar
• 22. Nguyen TA, Jo MH, Choi YG et al. Functional anatomy of the human microprocessor. Cell 161(6), 1374–1387 (2015).
  Medline CASGoogle Scholar
• 23. Han J, Lee Y, Yeom K-H et al. Molecular basis for the recognition of primary microRNAs by the Drosha–DGCR8 complex. Cell 125(5), 887–901 (2006).
  Medline CASGoogle Scholar
• 24. Yamazawa R, Jiko C, Choi S et al. Structural basis for selective binding of export cargoes by exportin-5. Structure 26(10), 1393–1398.e2 (2018).
  Medline CASGoogle Scholar
• 25. Kehlenbach RH, Dickmanns A, Kehlenbach A, Guan T, Gerace L. A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export. J. Cell Biol. 145(4), 645–657 (1999).
  Medline CASGoogle Scholar
• 26. Song MS, Rossi JJ. Molecular mechanisms of Dicer: endonuclease and enzymatic activity. Biochem. J. 474(10), 1603–1618 (2017).
  Medline CASGoogle Scholar
• 27. MacRae IJ, Zhou K, Li F et al. Structural basis for double-stranded RNA processing by Dicer. Science 311(5758), 195–198 (2006).
  Medline CASGoogle Scholar
• 28. Wu J, Yang J, Cho WC, Zheng Y. Argonaute proteins: structural features, functions and emerging roles. J. Adv. Res. 24, 317–324 (2020).
  Medline CASGoogle Scholar
• 29. Iwasaki S, Kobayashi M, Yoda M et al. Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Mol. Cell 39(2), 292–299 (2010).
  Medline CASGoogle Scholar
• 30. Johnston M, Geoffroy MC, Sobala A, Hay R, Hutvagner G. HSP90 protein stabilizes unloaded Argonaute complexes and microscopic P-bodies in human cells. Mol. Biol. Cell 21(9), 1462–1469 (2010).
  Medline CASGoogle Scholar
• 31. Miyoshi T, Takeuchi A, Siomi H, Siomi MC. A direct role for Hsp90 in pre-RISC formation in Drosophila. Nat. Struct. Mol. Biol. 18(4), 516 (2011).
  CASGoogle Scholar
• 32. Iwasaki S, Sasaki HM, Sakaguchi Y, Suzuki T, Tadakuma H, Tomari Y. Defining fundamental steps in the assembly of the Drosophila RNAi enzyme complex. Nature 521(7553), 533–536 (2015).
  Medline CASGoogle Scholar
• 33. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115(2), 199–208 (2003).
  Medline CASGoogle Scholar
• 34. Saliminejad K, Khorshid HRK, Fard SS, Ghaffari S. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J. Cell. Physiol. 234(5), 5451–5465 (2019).
  Medline CASGoogle Scholar
• 35. Shukla G, Singh J, Barik S. microRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol. 3(3), 83–92 (2011).
  Medline CASGoogle Scholar
• 36. Brummer A, Hausser J. microRNA binding sites in the coding region of mRNAs: extending the repertoire of post-transcriptional gene regulation. Bioessays 36(6), 617–626 (2014).
  MedlineGoogle Scholar
• 37. Gerresheim GK, Dunnes N, Nieder-Rohrmann A et al. microRNA-122 target sites in the hepatitis C virus RNA NS5B coding region and 3′ untranslated region: function in replication and influence of RNA secondary structure. Cell. Mol. Life Sci. 74(4), 747–760 (2017).
  Medline CASGoogle Scholar
• 38. Biegel JM, Henderson E, Cox EM et al. Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5′ untranslated region of hepatitis C virus RNA. Virology 507, 231–241 (2017).
  Medline CASGoogle Scholar
• 39. Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA, Vasconcelos MH. microRNA regulation of core apoptosis pathways in cancer. Eur. J. Cancer 47(2), 163–174 (2011).
  Medline CASGoogle Scholar
• 40. Rao X, Di Leva G, Li M et al. microRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 30(9), 1082–1097 (2011).
  Medline CASGoogle Scholar
• 41. Li Y, Huang J, Guo M, Zuo X. microRNAs regulating signaling pathways: potential biomarkers in systemic sclerosis. Genomics Proteomics Bioinformatics 13(4), 234–241 (2015).
  MedlineGoogle Scholar
• 42. Yu MM, Xu Y, Pan LL et al. miR-10b downregulated by DNA methylation acts as a tumor suppressor in HPV-positive cervical cancer via targeting Tiam 1. Cell. Physiol. Biochem. 51(4), 1763–1777 (2018).
  Medline CASGoogle Scholar
• 43. Abisoye-Ogunniyan A, Lin H, Ghebremedhin A et al. Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c. Cancer Lett. 431, 1–10 (2018).
  Medline CASGoogle Scholar
• 44. Liu K, Xu C, Lei M et al. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA. J. Biol. Chem. 293(19), 7344–7354 (2018).
  Medline CASGoogle Scholar
• 45. Filion GJP, Zhenilo S, Salozhin S, Yamada D, Prokhortchouk E, Defossez P-A. A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol. Cell. Biol. 26(1), 169–181 (2006).
  Medline CASGoogle Scholar
• 46. Bell RE, Golan T, Sheinboim D et al. Enhancer methylation dynamics contribute to cancer plasticity and patient mortality. Genome Res. 26(5), 601–611 (2016).
  Medline CASGoogle Scholar
• 47. Zhang JK, Li YS, Zhang CD, Dai DQ. Upregulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer. Cancer Cell Int. 17, 28 (2017).
  MedlineGoogle Scholar
• 48. Fu Q, Shi H, Chen C. Roles of bta-miR-29b promoter regions DNA methylation in regulating miR-29b expression and bovine viral diarrhea virus NADL replication in MDBK cells. Arch. Virol. 162(2), 401–408 (2017).
  Medline CASGoogle Scholar
• 49. Periyasamy P, Thangaraj A, Guo ML, Hu GK, Callen S, Buch S. Epigenetic promoter DNA methylation of miR-124 promotes HIV-1 Tat-mediated microglial activation via MECP2-STAT3 axis. J. Neurosci. 38(23), S367–S383 (2018).
  Google Scholar
• 50. Glaich O, Parikh S, Bell RE et al. DNA methylation directs microRNA biogenesis in mammalian cells. Nat. Commun. 10(1), 5657 (2019). •• MECP2 binding to methylated miRNA loci halts RNA Pol II elongation, leading to enhanced processing of pri-miRNA by Drosha.
  MedlineGoogle Scholar
• 51. Shukla S, Kavak E, Gregory M et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 479(7371), 74–79 (2011).
  Medline CASGoogle Scholar
• 52. Maunakea AK, Chepelev I, Cui K, Zhao K. Intragenic DNA methylation modulates alternative splicing by recruiting MECP2 to promote exon recognition. Cell Res. 23(11), 1256–1269 (2013).
  Medline CASGoogle Scholar
• 53. Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389(6648), 251–260 (1997).
  Medline CASGoogle Scholar
• 54. Oudet P, Gross-Bellard M, Chambon P. Electron microscopic and biochemical evidence that chromatin structure is a repeating unit. Cell 4(4), 281–300 (1975).
  Medline CASGoogle Scholar
• 55. Allan J, Hartman PG, Crane-Robinson C, Aviles FX. The structure of histone H1 and its location in chromatin. Nature 288(5792), 675–679 (1980).
  Medline CASGoogle Scholar
• 56. Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13(5), 343–357 (2012).
  Medline CASGoogle Scholar
• 57. Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311(5762), 844–847 (2006).
  Medline CASGoogle Scholar
• 58. Vettese-Dadey M, Grant PA, Hebbes TR, Crane-Robinson C, Allis CD, Workman JL. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 15(10), 2508–2518 (1996).
  Medline CASGoogle Scholar
• 59. Huang G, Zhang G, Yu Z. Computational prediction and analysis of histone H3k27me1-associated miRNAs. Biochim. Biophys. Acta Proteins Proteom. 1869(1), 140539 (2021).
  Medline CASGoogle Scholar
• 60. Jing PY, Zhao N, Ye MX et al. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling. Cancer Lett. 427, 38–48 (2018).
  Medline CASGoogle Scholar
• 61. Du C, Lv CH, Feng Y, Yu SW. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression. J. Exp. Clin. Cancer Res. 39(1), (2020).
  Google Scholar
• 62. Cai H, An Y, Chen X et al. Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via upregulation of insulin-like growth factor 2. Oncotarget 7(52), 86857–86870 (2016).
  MedlineGoogle Scholar
• 63. Ding S, Zhang Q, Luo S et al. BCL-6 suppresses miR-142-3p/5p expression in SLE CD4(+) T cells by modulating histone methylation and acetylation of the miR-142 promoter. Cell. Mol. Immunol. 17(5), 474–482 (2020).
  Medline CASGoogle Scholar
• 64. Zhou MR, Zeng JP, Wang XM et al. Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia. Oncotarget 6(2), 1249–1261 (2015).
  MedlineGoogle Scholar
• 65. Karkhanis V, Alinari L, Ozer HG et al. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that downregulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma. J. Biol. Chem. 295(5), 1165–1180 (2020).
  MedlineGoogle Scholar
• 66. Zhang Q, Xu L, Wang JJ et al. KDM5C expedites lung cancer growth and metastasis through epigenetic regulation of microRNA-133a. Onco Targets Ther. 14, 1187–1204 (2021).
  MedlineGoogle Scholar
• 67. Zhang S, Chen P, Huang ZA et al. Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci. Rep. 5, 9787 (2015).
  Medline CASGoogle Scholar
• 68. Wu R, Zeng J, Yuan J et al. microRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J. Clin. Investig. 128(6), 2551–2568 (2018).
  MedlineGoogle Scholar
• 69. Zhu J, Han S. Histone deacetylase 10 exerts anti-tumor effects on cervical cancer via a novel microRNA-223/TXNIP/Wnt/beta-catenin pathway. IUBMB Life doi: 10.1002/iub.2448 (2021) (Epub ahead of print).
  Google Scholar
• 70. Peng XL, Chang H, Gu YY et al. 3,6-dihydroxyflavone suppresses breast carcinogenesis by epigenetically regulating miR-34a and miR-21. Cancer Prev. Res. (Phila.) 8(6), 509–517 (2015).
  Medline CASGoogle Scholar
• 71. Zhu H, Wang C. HDAC2-mediated proliferation of trophoblast cells requires the miR-183/FOXA1/IL-8 signaling pathway. J. Cell. Physiol. 236(4), 2544–2558 (2021).
  Medline CASGoogle Scholar
• 72. Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 15(11), 703–708 (2014).
  Medline CASGoogle Scholar
• 73. Handa H, Hashimoto A, Hashimoto S, Sugino H, Oikawa T, Sabe H. Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells. Cell Commun. Signal. 16(1), 94 (2018). • Histone modifications of certain miRNA loci are different between epithelial cells and nonepithelial cells.
  Medline CASGoogle Scholar
• 74. Li Y, Li H, Zhou L. EZH2-mediated H3K27me3 inhibits ACE2 expression. Biochem. Biophys. Res. Commun. 526(4), 947–952 (2020).
  Medline CASGoogle Scholar
• 75. Yu J, Wang L, Pei P et al. Reduced H3K27me3 leads to abnormal Hox gene expression in neural tube defects. Epigenetics Chromatin 12(1), 76 (2019).
  Medline CASGoogle Scholar
• 76. Zhang B, Zheng H, Huang B et al. Allelic reprogramming of the histone modification H3K4me3 in early mammalian development. Nature 537(7621), 553–557 (2016).
  Medline CASGoogle Scholar
• 77. Clouaire T, Webb S, Skene P et al. Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes Dev. 26(15), 1714–1728 (2012).
  Medline CASGoogle Scholar
• 78. Hu D, Gao X, Cao K et al. Not all H3K4 methylations are created equal: Mll2/COMPASS dependency in primordial germ cell specification. Mol. Cell 65(3), 460–475.e6 (2017).
  Medline CASGoogle Scholar
• 79. Douillet D, Sze CC, Ryan C et al. Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation. Nat. Genet. 52(6), 615–625 (2020). •• MLL2-mediated H3K4me3 modification regulates target gene expression by antagonizing H3K27me3 and DNA methylation.
  Medline CASGoogle Scholar
• 80. Tate CM, Lee JH, Skalnik DG. CXXC finger protein 1 restricts the Setd1A histone H3K4 methyltransferase complex to euchromatin. FEBS J. 277(1), 210–223 (2010).
  Medline CASGoogle Scholar
• 81. Carlone DL, Lee JH, Young SR et al. Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein. Mol. Cell. Biol. 25(12), 4881–4891 (2005).
  Medline CASGoogle Scholar
• 82. Ning X, Shi Z, Liu X et al. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. Cancer Lett. 359(2), 198–205 (2015).
  Medline CASGoogle Scholar
• 83. Hu Y, Wu F, Liu Y, Zhao Q, Tang H. DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A. Clin. Epigenetics 11(1), 186 (2019).
  Medline CASGoogle Scholar
• 84. Willyard C. An epigenetics gold rush: new controls for gene expression. Nature 542(7642), 406–408 (2017).
  Medline CASGoogle Scholar
• 85. Xhemalce B, Robson SC, Kouzarides T. Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell 151(2), 278–288 (2012).
  Medline CASGoogle Scholar
• 86. Pandolfini L, Barbieri I, Bannister AJ et al. METTL1 promotes let-7 microRNA processing via m7G methylation. Mol. Cell 74(6), 1278–1290.e9 (2019). •• m7G promotes processing by antagonizing G-quadruplex structures in miRNA precursors.
  Medline CASGoogle Scholar
• 87. Zhao LY, Song J, Liu Y, Song CX, Yi C. Mapping the epigenetic modifications of DNA and RNA. Protein Cell 11(11), 792–808 (2020).
  Medline CASGoogle Scholar
• 88. Berulava T, Rahmann S, Rademacher K, Klein-Hitpass L, Horsthemke B. N6-adenosine methylation in miRNAs. PLOS ONE 10(2), e0118438 (2015).
  MedlineGoogle Scholar
• 89. Alarcón CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary microRNAs for processing. Nature 519(7544), 482–485 (2015).
  Medline CASGoogle Scholar
• 90. Alarcon CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162(6), 1299–1308 (2015).
  Medline CASGoogle Scholar
• 91. Wang H, Deng Q, Lv Z et al. N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1. Mol. Cancer 18(1), 181 (2019).
  Medline CASGoogle Scholar
• 92. Han J, Wang J-Z, Yang X et al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol. Cancer 18(1), 110 (2019).
  MedlineGoogle Scholar
• 93. Zhang J, Bai R, Li M et al. Excessive miR-25-3p maturation via N⁶-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Nat. Commun. 10(1), 1858 (2019).
  MedlineGoogle Scholar
• 94. Xu K, Mo Y, Li D et al. N-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia–reperfusion injury. Ther. Adv. Chronic Dis. 11, 2040622320916024 (2020).
  Google Scholar
• 95. Wang P, Wang ZW, Zhang M, Wu Q, Shi F, Yuan S. KIAA1429 and ALKBH5 oppositely influence aortic dissection progression via regulating the maturation of pri-miR-143-3p in an m6A-dependent manner. Front. Cell Dev. Biol. 9, 668377 (2021).
  MedlineGoogle Scholar
• 96. Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m⁶A RNA methylation. Nat. Rev. Genet. 15(5), 293–306 (2014).
  Medline CASGoogle Scholar
• 97. Wang X, Lu Z, Gomez A et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505(7481), 117–120 (2014).
  MedlineGoogle Scholar
• 98. Chaulk SG, Thede GL, Kent OA et al. Role of pri-miRNA tertiary structure in miR-17∼92 miRNA biogenesis. RNA Biol. 8(6), 1105–1114 (2011).
  Medline CASGoogle Scholar
• 99. Zhao H, Li J, Yan X, Bian X. lncRNA MAFG-AS1 suppresses the maturation of miR-34a to promote glioblastoma cell proliferation. Cancer Manag. Res. 13, 3493–3501 (2021).
  Medline CASGoogle Scholar
• 100. Han K, Wang FW, Cao CH et al. circLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17. Mol. Cancer 19(1), 60 (2020).
  Medline CASGoogle Scholar
• 101. Yu Y, Nangia-Makker P, Farhana L, Majumdar APN. A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells. Mol. Cancer 16(1), 155 (2017).
  MedlineGoogle Scholar
• 102. Liz J, Portela A, Soler M et al. Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Mol. Cell 55(1), 138–147 (2014).
  Medline CASGoogle Scholar
• 103. Tian T, Lv XB, Pan GK et al. Long noncoding RNA MPRL promotes mitochondrial fission and cisplatin chemosensitivity via disruption of pre-miRNA processing. Clin. Cancer Res. 25(12), 3673–3688 (2019).
  Medline CASGoogle Scholar
• 104. Li YZ, Song Y, Wang ZH, Zhang ZY, Lu MM, Wang YX. Long non-coding RNA LINC01787 drives breast cancer progression via disrupting miR-125b generation. Front. Oncol. 5(9), 1140 (2019).
  Google Scholar
• 105. Ahn J-H, Lee H-S, Lee J-S et al. nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer. Nat. Commun. 9(1), 1166 (2018).
  MedlineGoogle Scholar
• 106. Tang R, Li L, Zhu D et al. Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogenesis at the posttranscriptional level in the nucleus: evidence for a microRNA hierarchy system. Cell Res. 22(3), 504–515 (2012).
  Medline CASGoogle Scholar
• 107. Zisoulis DG, Kai ZS, Chang RK, Pasquinelli AE. Autoregulation of microRNA biogenesis by let-7 and Argonaute. Nature 486(7404), 541–544 (2012).
  Medline CASGoogle Scholar
• 108. Wang D, Sun X, Wei Y et al. Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level. Nucleic Acids Res. 46(4), 2012–2029 (2018). •• First evidence that miR-122 promotes hepatocellular carcinoma cell apoptosis by directly silencing the biogenesis of cell survival oncomiR miR-21 at a post-transcriptional level.
  Medline CASGoogle Scholar
• 109. Földes-Papp Z, König K, Studier H et al. Trafficking of mature miRNA-122 into the nucleus of live liver cells. Curr. Pharm. Biotechnol. 10(6), 569–578 (2009).
  MedlineGoogle Scholar
• 110. Tseng C-F, Chen L-T, Wang H-D, Liu Y-H, Shiah S-G. Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness. Cancer Sci. 113(5), 1601–1612 (2022).
  Medline CASGoogle Scholar
• 111. Leaderer D, Hoffman AE, Zheng T et al. Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. Int. J. Mol. Epidemiol. Genet. 2(1), 9–18 (2011).
  Medline CASGoogle Scholar
• 112. Hoffend NC, Magner WJ, Tomasi TB. The epigenetic regulation of Dicer and microRNA biogenesis by panobinostat. Epigenetics 12(2), 105–112 (2017).
  MedlineGoogle Scholar
• 113. van den Beucken T, Koch E, Chu K et al. Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat. Commun. 5, 5203 (2014).
  MedlineGoogle Scholar
• 114. Peng F, Xu J, Cui B et al. Oncogenic AURKA-enhanced N(6)-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells. Cell Res. 31(3), 345–361 (2021).
  Medline CASGoogle Scholar
• 115. Min KW, Zealy RW, Davila S et al. Profiling of m6A RNA modifications identified an age-associated regulation of AGO2 mRNA stability. Aging Cell 17(3), e12753 (2018).
  MedlineGoogle Scholar
• 116. Dong JS, Wu B, Chen XH. circPSMC3 inhibits prostate cancer cell proliferation by downregulating DGCR8. Eur. Rev. Med. Pharmacol. Sci. 24(5), 2264–2270 (2020).
  MedlineGoogle Scholar
• 117. Frixa T, Sacconi A, Cioce M et al. microRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration. Carcinogenesis 39(2), 293–304 (2018). • miR-128-3p causes extensive downregulation of miRNA expression by targeting Drosha and Dicer, two key enzymes in miRNA processing.
  Medline CASGoogle Scholar
• 118. Martello G, Rosato A, Ferrari F et al. A microRNA targeting Dicer for metastasis control. Cell 141(7), 1195–1207 (2010).
  Medline CASGoogle Scholar
• 119. Paraskevopoulou MD, Georgakilas G, Kostoulas N et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 41(Web Server issue), W169–W173 (2013).
  MedlineGoogle Scholar
• 120. Mechtler P, Johnson S, Slabodkin H, Cohanim AB, Brodsky L, Kandel ES. The evidence for a microRNA product of human DROSHA gene. RNA Biol. 14(11), 1508–1513 (2017).
  MedlineGoogle Scholar
• 121. Bosia C, Osella M, Baroudi ME, Cora D, Caselle M. Gene autoregulation via intronic microRNAs and its functions. BMC Syst. Biol. 6, 131 (2012).
  Medline CASGoogle Scholar
• 122. Redis RS, Vela LE, Lu W et al. Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol. Cell 61(4), 520–534 (2016).
  Medline CASGoogle Scholar
• 123. Chakraborty C, Sharma AR, Sharma G, Doss CGP, Lee SS. Therapeutic miRNA and siRNA: moving from bench to clinic as next-generation medicine. Mol. Ther. Nucleic Acids 8, 132–143 (2017).
  Medline CASGoogle Scholar
• 124. Watts JK, Corey DR. Silencing disease genes in the laboratory and the clinic. J. Plant Pathol. 226(2), 365–379 (2012).
  CASGoogle Scholar
• 125. Baretti M, Azad NS. The role of epigenetic therapies in colorectal cancer. Curr. Probl. Cancer 42(6), 530–547 (2018).
  MedlineGoogle Scholar
• 126. Lujambio A, Ropero S, Ballestar E et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67(4), 1424–1429 (2007).
  Medline CASGoogle Scholar
• 127. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 66(3), 1277–1281 (2006).
  Medline CASGoogle Scholar